. 2021 Sep 10;11:18081. doi: 10.1038/s41598-021-95879-7

Table 4.

CAs frequency in AFB₂ and resveratrol treated groups.

CAs type	Group I	Group II	Group III	Group IV	Group V	Group VI
Break	N.O	N.O	N.O	53.18 ± 1.42^a	40.10 ± 1.38^b	26.94 ± 1.16^c
Fragment	N.O	N.O	N.O	38.76 ± 1.24^a	26.37 ± 1.14^b	17.48 ± 0.98^c
Acentric	N.O	N.O	N.O	25.14 ± 1.10^a	16.53 ± 1.10^b	11.40 ± 0.90^c
Dicentric	N.O	N.O	N.O	18.74 ± 1.00^a	11.63 ± 0.90^b	7.35 ± 0.52^c
Gap	0.22 ± 0.13^d	0.14 ± 0.08^d	0.11 ± 0.06^d	13.78 ± 0.96^a	8.66 ± 0.86^b	3.75 ± 0.55^c
Ring	N.O	N.O	N.O	9.67 ± 0.88^a	5.16 ± 0.68^b	1.88 ± 0.48^c

Values are shown as mean ± SEM (n = 6). Data shown with different letters^(a–d) in the same line are statistically significant (p < 0.05). Group I: control, Group II: 10 mg/kg b.w resveratrol, Group III: 20 mg/kg b.w resveratrol, Group IV: 20 µg/kg b.w AFB₂, Group V: 10 mg/kg b.w resveratrol + 20 µg/kg b.w AFB₂, Group VI: 20 mg/kg b.w resveratrol + 20 µg/kg b.w AFB₂.

N.O not observed.